genedrive plc (LON:GDR – Get Free Report) was up 12.5% during mid-day trading on Tuesday . The company traded as high as GBX 0.90 and last traded at GBX 0.90. Approximately 610,728 shares were traded during trading, a decline of 97% from the average daily volume of 19,215,541 shares. The stock had previously closed at GBX 0.80.
genedrive Trading Up 12.5%
The firm has a market cap of £9.27 million, a P/E ratio of -0.42 and a beta of -0.04. The company has a current ratio of 4.60, a quick ratio of 5.52 and a debt-to-equity ratio of 0.35. The company’s fifty day moving average price is GBX 0.83 and its two-hundred day moving average price is GBX 0.91.
About genedrive
ggenedrive plc is a pharmacogenetic testing company developing and commercialising a low cost, rapid, versatile and simple to use point of need pharmacogenetic platform for the diagnosis of genetic variants. This helps clinicians to quickly access key genetic information that will aid them make the right choices over the right medicine or dosage to use for an effective treatment, particularly important in time-critical emergency care healthcare paradigms. Based in the UK, the Company is at the forefront of Point of Care pharmacogenetic testing in emergency healthcare.
Further Reading
- Five stocks we like better than genedrive
- Do not delete, read immediately
- INVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting Off
- Can Any Expenses Be Deducted From Capital Gains Tax?
- Buffett, Gates and Bezos Quietly Dumping Stocks—Here’s Why
- The Last Gold Bull Market
Receive News & Ratings for genedrive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for genedrive and related companies with MarketBeat.com's FREE daily email newsletter.
